An article about our suggested Code of Good Practice for Manufacturers written by Chinaniso Majoni, Senior Nomenclature Developer & Quality Lead at the GMDN Agency

CEO Blog by Deniz Bruce

A feature on the requirements of a medical device nomenclature written by Edward Glenn, Senior Nomenclature Developer & Business Development Lead at the GMDN Agency

The GMDN Agency owns the copyright to the GMDN as this helps us protect and maintain data integrity for all

The GMDN Agency CEO, Deniz Bruce, and Senior Clinical Lead, Dr Barry Daniels, attended the IMDRF (International Medical Device Regulators Forum) Meeting

MHRA and ANVISA representatives have joined the Authorities Strategic Advisory Group (ASAG) committee, which represents medical device regulators that use the GMDN.

The GMDN Agency delivered three virtual strategy workshops this month (March 2023) as part of our Corporate Strategy 2022 – 2026 implementation.

The GMDN has been listening to the views of nomenclature users to help shape the future of medical device identification.

The GMDN Agency are pleased to welcome a new team member to help us communicate our strategy and engage with all of our stakeholders.

On 26th January 2023 the GMDN was approved as a fundamental standard supporting the identification of medical devices for the NHS